Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Multiple Myeloma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Plasmacytoma 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Graft vs Host Disease 1Bronchiolitis Obliterans Syndrome 1

Interventions

Cyclophosphamide 25Tacrolimus 17fludarabine phosphate 14Mycophenolic Acid 14Antilymphocyte Serum 13Cyclosporine 12Methylprednisolone 11Methotrexate 11Melphalan 11Busulfan 11fludarabine 10Radiotherapy 10Peripheral Blood Stem Cell Transplantation 10Filgrastim 10Whole-Body Irradiation 9Sirolimus 9Etoposide 5Therapeutics 4Flow Cytometry 4Cord Blood Stem Cell Transplantation 4Alemtuzumab 4thymoglobulin 3Stem Cell Transplantation 3Rituximab 3Prednisone 3Hematopoietic Stem Cell Transplantation 3Granulocyte Colony-Stimulating Factor 3Cyclosporins 3Amplified Fragment Length Polymorphism Analysis 3Leucovorin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × milatuzumab × Plasma cell × Clear all
NCT01663766 2021-08-19

Phase I Study of Milatuzumab for Graft Versus Host Disease

Gilead Sciences

Phase 1 Terminated
12 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡